JOHNSON & JOHNSON — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| MORIKIS JOHN G | — | Purchase | 1,250 | $206.15 | $257,688 | 1,849 | Nov 26, 2025 |
| REED JOHN C | EVP, Innovative Medicine, R&D | Sale | 21,721 | $192.71 | $4,185,854 | 10,658 | Oct 17, 2025 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sale | 56,471 | $177.81 | $10,041,109 | 178,013 | Sep 4, 2025 |
| Forminard Elizabeth | Executive VP, General Counsel | Option Exercise | 11,521 | $115.67 | $1,332,634 | 22,423 | Aug 29, 2025 |
| Duato Joaquin | CEO and Chairman of the Board | Sale | 125,824 | $179.21 | $22,548,919 | 275,967 | Aug 22, 2025 |
| Wolk Joseph J | Exec VP, CFO | Option Exercise | 16,820 | $101.87 | $1,713,453 | 30,820 | Aug 15, 2025 |
| REED JOHN C | EVP, Innovative Medicine, R&D | Sale | 19,137 | $163.55 | $3,129,856 | 10,658 | Jul 17, 2025 |
| REED JOHN C | EVP, Innovative Medicine, R&D | Tax Withholding | 11,002 | $156.31 | $1,719,723 | 29,795 | May 1, 2025 |
| Duato Joaquin | CEO and Chairman of the Board | Gift | 130,852 | — | — | 275,967 | Mar 18, 2025 |
| Decker Robert J | VP Corporate Controller | Sale | 6,999 | $165.88 | $1,160,994 | 21,001 | Feb 25, 2025 |
| REED JOHN C | EVP, Innovative Medicine, R&D | Option Exercise | 1,350 | — | — | 15,927 | Feb 18, 2025 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Option Exercise | 1,302 | — | — | 167,221 | Feb 18, 2025 |
| Schmid Timothy | EVP, WW Chair, MedTech | Option Exercise | 2,806 | — | — | 17,904 | Feb 14, 2025 |
| Schmid Timothy | EVP, WW Chair, MedTech | Tax Withholding | 193 | $155.26 | $29,965 | 13,346 | Feb 14, 2025 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Option Exercise | 5,837 | — | — | 96,674 | Feb 14, 2025 |
| Wolk Joseph J | Exec VP, CFO | Option Exercise | 4,014 | — | — | 5,286 | Feb 14, 2025 |
| Swanson James D. | EVP, CIO | Tax Withholding | 152 | $155.26 | $23,600 | 14,867 | Feb 14, 2025 |
| Duato Joaquin | CEO and Chairman of the Board | Tax Withholding | 8,386 | $156.71 | $1,314,170 | 406,819 | Feb 14, 2025 |
| Decker Robert J | VP Corporate Controller | Tax Withholding | 254 | $156.71 | $39,804 | 19,777 | Feb 14, 2025 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Option Exercise | 1,830 | — | — | 21,921 | Feb 14, 2025 |
| Mulholland Kristen | EVP, Chief HR Officer | Option Exercise | 1,601 | — | — | 14,576 | Feb 13, 2025 |
| Forminard Elizabeth | Executive VP, General Counsel | Tax Withholding | 267 | $156.71 | $41,842 | 9,360 | Feb 13, 2025 |
| Duato Joaquin | CEO and Chairman of the Board | Option Exercise | 126,369 | $100.06 | $12,644,482 | 489,671 | Feb 7, 2025 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Option Exercise | 32,762 | $100.06 | $3,278,166 | 115,028 | Feb 7, 2025 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Option Exercise | 58,504 | $100.06 | $5,853,910 | 213,355 | Feb 7, 2025 |
| Wolk Joseph J | Exec VP, CFO | Option Exercise | 13,015 | $100.06 | $1,302,281 | 13,015 | Feb 7, 2025 |
| WEINBERGER MARK A | — | Purchase | 1,000 | $147.22 | $147,220 | 1,000 | Dec 12, 2024 |
| Wolk Joseph J | Exec VP, CFO | Gift | 55 | — | — | 68,835 | Oct 17, 2024 |
| Decker Robert J | VP Corporate Controller | Sale | 5,635 | $165.06 | $930,113 | 18,973 | Aug 30, 2024 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Option Exercise | 9,809 | — | — | 24,852 | Jul 8, 2024 |
| REED JOHN C | EVP, Innovative Medicine, R&D | Tax Withholding | 10,984 | $144.59 | $1,588,177 | 14,577 | May 1, 2024 |
| REED JOHN C | EVP, Innovative Medicine, R&D | Tax Withholding | 10,984 | $144.59 | $1,588,177 | 11,577 | May 1, 2024 |
| Woods Eugene A. | — | Purchase | 100 | $145.53 | $14,553 | 250 | Apr 30, 2024 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Sale | 8,891 | $162.16 | $1,441,765 | 15,043 | Mar 13, 2024 |
| Wengel Kathryn E | EVP, Chief TO and Risk Officer | Option Exercise | 651 | — | — | 82,599 | Feb 13, 2024 |
| Wolk Joseph J | Exec VP, CFO | Option Exercise | 1,780 | — | — | 69,663 | Feb 13, 2024 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Option Exercise | 1,302 | — | — | 155,517 | Feb 13, 2024 |
| Swanson James D. | EVP, CIO | Tax Withholding | 195 | $157.85 | $30,781 | 14,570 | Feb 13, 2024 |
| Schmid Timothy | EVP, WW Chair, MedTech | Option Exercise | 499 | — | — | 13,290 | Feb 13, 2024 |
| Hait William | See Remarks | Option Exercise | 834 | — | — | 39,074 | Feb 13, 2024 |
| Forminard Elizabeth | Executive VP, General Counsel | Option Exercise | 651 | — | — | 8,576 | Feb 13, 2024 |
| Fasolo Peter | Exec VP, Chief HR Officer | Option Exercise | 925 | — | — | 112,550 | Feb 13, 2024 |
| Duato Joaquin | CEO and Chairman of the Board | Tax Withholding | 1,507 | $157.85 | $237,880 | 363,302 | Feb 13, 2024 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Option Exercise | 408 | — | — | 24,143 | Feb 13, 2024 |
| Decker Robert J | VP Corporate Controller | Tax Withholding | 86 | $157.85 | $13,575 | 18,973 | Feb 13, 2024 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Tax Withholding | 2,136 | $157.40 | $336,206 | 23,735 | Feb 12, 2024 |
| Wolk Joseph J | Exec VP, CFO | Option Exercise | 3,716 | — | — | 78,699 | Feb 12, 2024 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Tax Withholding | 13,403 | $157.40 | $2,109,632 | 154,215 | Feb 12, 2024 |
| Swanson James D. | EVP, CIO | Tax Withholding | 1,695 | $157.40 | $266,793 | 14,318 | Feb 12, 2024 |
| Schmid Timothy | EVP, WW Chair, MedTech | Option Exercise | 4,911 | — | — | 14,853 | Feb 12, 2024 |